The results of the current study are similar to those of previous studies reporting that high cyclin D1 expression significantly correlates with an improved prognosis, while low expression of cyclin D1 correlates with a poor prognosis of ccRCC (26–28). This evidence concerns the gene CCND1 and nonpapillary renal cell carcinoma.